![](/accounts/npace/images/logo.jpg)
Updates in Pharmacological Management of Urinary Tract Infections
-
Register
- User - $40
This session will examine clinically relevant updates for managing urinary tract infections, one of the most frequently encountered infections in outpatient practice. Session topics include:
[1] recent trends in urinary pathogen resistance and associated empiric approaches based on these resistance trends
[2] evidence for non-antibiotic approaches to limit recurrent urinary tract infections
[3] considerations for assessing urinary specimen results
[4] management of asymptomatic bacteriuria
[5] anti-infective specific practice pearls throughout the session.
Credits: 1.50 contact hours; 1.50 are pharmacology
Expiration Date: June 30th, 2025
$40
LEARNING OBJECTIVES
After taking part in this educational activity, participants should be better able to:
-As a result of this activity, the learner will be able to describe resistance trends of urinary pathogens in the community
-As a result of this activity, the learner will be able to formulate effective evidence-based treatment regimens for urinary tract infections
-As a result of this activity, the learner will be able to formulate effective evidence-based regimens for prevention of recurrent urinary tract infections
![Speaker image](https://cbe13ccc2f6528c6f41a-22681ccf5762815622e0a742887a3d04.ssl.cf2.rackcdn.com/npace_81483d5f1090858bbe3bd2b1550c67d6.jpeg)
Eric Wombwell, PharmD, BCIDP
Clinical Associate Professor
University of Missouri, Kansas City, School of Pharmacy
Dr. Eric Wombwell is a Board-Certified Infectious Diseases Pharmacist and Clinical Associate Professor for the Department of Pharmacy Practice and Administration at the University of Missouri - Kansas City, School of Pharmacy. Eric completed his PharmD degree at the University of Missouri Kansas City, followed by an ASHP accredited pharmacy practice residency at the Kansas City VA Medical Center. Following residency, he accepted a full-time non-tenured clinical faculty position at the University of Missouri – Kansas City, School of Pharmacy. His teaching responsibilities include infectious diseases topics throughout the curriculum. Eric also has a clinical appointment at Centerpoint Medical Center rounding with the infectious diseases consult team and supporting antimicrobial stewardship efforts at the facility.
Eric is regularly published in pharmacy and infectious diseases research and is frequently invited to deliver continuing education presentations locally and nationally to various health-professional audiences. He is recognized for excellence in teaching through various awards, including the “Missouri Pharmacist Association - UMKC Faculty Member of the Year” in 2016, and the “University of Missouri- Kansas City Provost’s Award for Excellence in Teaching” in 2014.
CE INFORMATION
Obtain Your Credits
To earn credits for this activity, navigate to the Content(s) tab and complete all course components in the following order: 1) watch the course presentation video; 2) complete the course evaluation; 3) pass the post-test with a score of 2/3 (66.7%) or higher. You may retake the post-test until a passing score is achieved, at which point you will be able to view/print a copy of your certificate of completion. This online certificate will also be saved within your profile 'My Dashboard' -> 'Transcript/Certificates Earned' for future access.
Designation Statement
NPACE designates this educational activity for a maximum of 1.50 contact hours, of which 1.50 is pharmacology credit. Participants should claim only credit commensurate with the extent of their participation in the activity.
Accreditation Statement
Nurse Practitioner Associates for Continuing Education (NPACE) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation (ANCC).
In addition to ANCC, NPACE is approved as a provider of continuing education in nursing by: the California Board of Registered Nursing, Provider Number CEP8720 and Florida CE Broker #50-1476.
DISCLOSURES
Faculty
Contributing faculty, Eric Wombwell, PharmD, BCIDP have disclosed have disclosed no relevant financial relationships.
Planners
All planners and contributors involved in this educational activity have disclosed no relevant financial relationships.
Disclaimer
The material presented in this continuing education program is being made available for educational purposes only and is not intended to represent the best or only methods, medications and/or guidelines appropriate for the medical situation discussed. Rather the material is intended to present an approach, view, statement, or opinion of the presenter(s), which may be helpful, or of interest to other practitioners and should not be used by clinicians without the evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. NPACE disclaims any liability, loss, injury, or damage incurred as a consequence, directly or indirectly, of the use and application of any information given in a presentation.
Disclosure of Unlabeled Use
This educational activity may mention the uses of products that are not approved by the FDA for the indication(s) being discussed. The presenter(s) are instructed to notify participants when they are discussing unapproved uses or investigational agents. The opinions related to unapproved uses of products are solely those of the presenter(s) and are not endorsed or recommended by NPACE. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Commercial Support
There is no commercial support for this activity.
Key:
![](/images/product-status-icons/complete-small.png)
![](/images/product-status-icons/next-small.png)
![](/images/product-status-icons/disabled-small.png)
![](/images/product-status-icons/optional-small.png)
![](/images/product-status-icons/locked-small.png)